苏36
09-10
For me, a US$638 billion backlog is impressive—but a backlog is only a promise until it becomes revenue, cash flow and ultimately free cash flow.

Tonight, I would focus on three things: RPO conversion, AI revenue growth, and cash generation. If Oracle can show that major AI contracts are moving into actual revenue faster than expected, while keeping margins under control, the backlog starts to look like a genuine earnings engine rather than a headline number.

The bigger question is capex. Oracle is spending heavily to build AI infrastructure before customers fully pay for it. That creates a dangerous gap if financing costs stay high.

So I would not buy simply because the backlog is huge. I want evidence that AI demand is converting into cash faster than Oracle is converting cash into data centres.

If tonight’s numbers prove that equation is turning positive, I think the market could start valuing Oracle very differently.

@Marktomarket [龇牙]

AI Giants Call for Slowdown — Can Chip Stocks Hold?
Chips closed Friday strong: SOXL +5.23%, Marvell +4.03% to $236.10, Intel +2.61% to $102.94, AMD +2.49%, Nvidia flat at −0.03%. Over the weekend Anthropic's Amodei called publicly for slowing frontier model development, and Altman and Musk both backed him, all three endorsing independent safety evaluations. By Monday's pre-open the sector had turned: SOXL −6.94%, Intel −3.68%, Marvell −3.49%, Nasdaq-100 futures −1%, the Nikkei −2%. Nobody has announced halted training or cut capex — this is a shock to expected demand, not to orders. Safety testing and inference burn compute too. Buy this dip?
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment